GO Term |
---|
extracellular region |
basement membrane |
extracellular space |
cytoplasm |
cytoskeleton |
plasma membrane |
membrane |
intracellular membrane-bounded organelle |
postsynaptic membrane |
collagen-containing extracellular matrix |
GO Term |
---|
calcium ion binding |
tubulin binding |
structural constituent of muscle |
laminin binding |
SH2 domain binding |
protein-containing complex binding |
alpha-actinin binding |
vinculin binding |
laminin-1 binding |
virus receptor activity |
Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
529 |
|
|||
641 | N-linked (GlcNAc...) asparagine | |||
649 | N-linked (GlcNAc...) asparagine | |||
661 | N-linked (GlcNAc...) asparagine | |||
726 |
|
|||
727 |
|
|||
729 |
|
|||
734 |
|
|||
884 |
|
Pathway Name | Organism |
---|---|
Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | Homo sapiens |
Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | Homo sapiens |
Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | Homo sapiens |
ECM proteoglycans | Homo sapiens |
EGR2 and SOX10-mediated initiation of Schwann cell myelination | Homo sapiens |
Non-integrin membrane-ECM interactions | Homo sapiens |
O-linked glycosylation | Homo sapiens |
Regulation of expression of SLITs and ROBOs | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:8927 | learning disability | |
DOID:9074 | systemic lupus erythematosus | |
DOID:9088 | parapsoriasis | |
DOID:9119 | acute myeloid leukemia | |
DOID:9256 | colorectal cancer | |
DOID:9351 | diabetes mellitus | |
DOID:9352 | type 2 diabetes mellitus | |
DOID:9360 | intrinsic asthma | |
DOID:9408 | acute myocardial infarction | |
DOID:9415 | allergic asthma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024